• We invest in U.S. middle-market buyouts in the Healthcare Services sector
  • We prefer founder-led and corporate carve-out businesses
  • We target businesses with EBITDA of $5-30 million, with the ability to scale significantly higher
  • We focus on investments that meet our overall firm strategy, rather than check size
  • We actively invest in control transactions